Last deal

$10M

Amount

Seed

Stage

01.05.2024

Date

2

all rounds

$10M

Total amount

General

About Company
Remepy is a biotechnology firm that combines medicine with tailored software applications to improve the efficacy and safety of drugs.

Industry

Sector :

Subsector :

founded date

2021

Number of employees

Company Type

For Profit

Last funding type

Seed

IPO status

Private

Description

Remepy provides a digital platform to pharma companies, allowing them to launch patentable software-drug combinations. By triggering brain mechanisms that positively influence the immune system, Remepy's platform enhances the effectiveness of drugs. The company specializes in pharma, biotech, digital health, software, mobile apps, immunology, and drug development. Founded in 2022 and based in Ramat Hasharon, Israel, Remepy is harnessing the power of the digital world to revolutionize the field of medicine.
Contacts